Tentarix Biotherapeutics

Enabling intelligent therapies with multifunctional biologics

We’re passionate about modernizing the standard of care through multifunctional biologics

Our team’s expertise forms the backbone of our commitment to redefining healthcare standards.

Our multifunctional biologics target specific cells, improving treatment efficacy while minimizing side effects.

In the past, the focus was on specific proteins for signaling within cells.
Our approach takes a holistic view, analyzing the functionally relevant cell surface proteome to design our multifunctional biologics, named Tentacles.
Our strategy involves binding signaling receptors and other cell markers, allowing us to leverage combinatorial avidity for precise targeting.

The Tentacle signifies our advanced approach for precisely targeting powerful biology for improved therapeutic outcomes.

The octopus is a highly intelligent creature. Just like an octopus's versatile tentacles, our therapies are precise, multi-functional, and intelligently designed to target specific cells for better health outcomes.

Andy  Kidd

Andy Kidd

  • Chief Executive Officer (CEO)
Stephen  Demarest

Stephen Demarest

  • Chief Scientific Officer (CSO)
Margaret  Karow

Margaret Karow

  • CHIEF DEVELOPMENT OFFICER
Brady  Johnson

Brady Johnson

  • SENIOR VICE PRESIDENT, OPERATIONS AND FINANCE